Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OD-141309 Pilot for Preoperative Skin Disinfection
NCT04703335Phase 1Unknown
- Sponsor
- Zaycor Healthcare
- Start
- Jun 2023
- Primary completion
- Aug 2023
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, single-blind trial of octenidine in surgical site infection (SSI) (4 arms), sponsored by Zaycor Healthcare. Primary endpoint: Antimicrobial efficacy. Status: unknown.
02
Drugs
octenidine
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT04703335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04703335.